Loading clinical trials...
Loading clinical trials...
A Randomized Clinical Trial to Determine the Efficacy of Early Versus Standard Antiretroviral Therapy in HIV Infected Adults With CD4+ T Cell Counts Between 200 and 350 Cells/mm3
Conditions
Interventions
Efavirenz
Lamivudine/Zidovudine
Locations
1
Haiti
Les Centres GHESKIO CIPRA CRS
Port-au-Prince, Haiti
Start Date
July 1, 2007
Primary Completion Date
September 1, 2009
Completion Date
September 1, 2009
Last Updated
October 15, 2014
NCT06192160
NCT05947890
NCT05989802
NCT06694805
NCT04142047
NCT02354014
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions